WOW
MultiCorp International, Inc. Announces the Hiring of Healthcare Executive to Become New Chief Executive OfficerPress Release | 02/11/2016
MultiCorp International, Inc. to Develop 4 Arm Study for Emergency Room Clinical Trials With Patented Migraine MedicinePress Release | 01/21/2016
MultiCorp International, Inc. Engages Compass Point Research to Collaborate With NDA Partners to Develop Patented Migraine Combination DrugPress Release | 03/31/2015
MultiCorp International, Inc Secures 1 Million Barrels Capacity Petroleum Tank Storage in Major Shipping PortPress Release | 08/12/2014
MultiCorp International, Inc Expands Energy Division to Source Crude Oil Products for Global SalesPress Release | 05/05/2014
MultiCorp International, Inc. Engages BioRegenerative Sciences, Inc. and North County Clinical Research to Develop Clinical Trial Procedures on Patented Migraine MedicinePress Release | 04/17/2014
MULTICORP INTERNATIONAL, INC ENGAGES BIOREGENERATIVE SCIENCES, INC and NORTH COUNTY CLINICAL RESEARCH TO DEVELOP CLINICAL TRIAL PROCEDURES ON PATENTED MIGRAINE MEDICINEPress Release | 04/16/2014
Multicorp International, Inc Acquires 70% Ownership in Patented Migraine Headache MedicationPress Release | 12/17/2013
MultiCorp International, Inc Signs Strategic Alliance Agreement With RMS Global Ltd.Press Release | 04/08/2013
MultiCorp International, Inc Update On Dawson Creek Development ProgressPress Release | 03/11/2013
MultiCorp International, Inc Receives Commitment For $50 Million Strategic Equity InvestmentPress Release | 03/06/2013
XTEND MEDICAL CORPORATION/MULTICORP INTERNATIONAL, INC NAME CHANGE AND SYMBOL CHANGE FINALIZEDPress Release | 08/27/2012
